APA (7th ed.) Citation

Jensen, M., Nielsen, S. F., Thiel, S., Hansen, S. W., Palarasah, Y., Svenningsen, P., . . . Jensen, B. L. Pilot Study of Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin Shows Reduced Intrarenal Complement Activation in Patients With Diabetes and CKD. Elsevier.

Chicago Style (17th ed.) Citation

Jensen, Mia, Steffen F. Nielsen, Steffen Thiel, Søren W.K Hansen, Yaseelan Palarasah, Per Svenningsen, Jesper N. Bech, Frank H. Mose, and Boye L. Jensen. Pilot Study of Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin Shows Reduced Intrarenal Complement Activation in Patients With Diabetes and CKD. Elsevier.

MLA (9th ed.) Citation

Jensen, Mia, et al. Pilot Study of Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin Shows Reduced Intrarenal Complement Activation in Patients With Diabetes and CKD. Elsevier.